The consumer-genomics company 23andMe just sold its biobank of customer genetic data to drugmaker Regeneron for $256 million.

cross-posted from: https://lemm.ee/post/64477597

Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.

  • SamotsvetyVIA [any]English
    13•26 days ago

    Not sure about remuneration, but in some countries like mine, or “israel”, giving your DNA to a what-is-basically-governmental company is heavily encouraged and there are campaigns to promote it